data13F

GANX – Gain Therapeutics Inc

Held by 1 of 60 tracked investors in their latest 13F filing

Investors holding1
Combined shares566,130
Combined reported value$979K

GANX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
David Einhorn 0.03 566,130$979KQ3 2026

Activity: last 4 quarters

No tracked investor changed this position in the last 4 quarters.

Added: opened or increased

No tracked investor opened or increased this position in the last 4 quarters.

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

1 peakQ3 2026: 1 tracked investors
Q1 2021: 1 tracked investorsQ2 2021: 1 tracked investorsQ3 2021: 1 tracked investorsQ4 2021: 1 tracked investorsQ1 2022: 1 tracked investorsQ2 2022: 1 tracked investorsQ3 2022: 1 tracked investorsQ4 2022: 1 tracked investorsQ1 2023: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2023: 1 tracked investorsQ4 2023: 1 tracked investorsQ1 2024: 1 tracked investorsQ2 2024: 1 tracked investorsQ3 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20212026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
David Einhorn566.1K566.1K566.1K566.1K566.1K566.1K566.1K566.1K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).